<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ReGen Therapeutics Limited</title>
	<atom:link href="http://www.regentherapeutics.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.regentherapeutics.com</link>
	<description>Just another WordPress site</description>
	<lastBuildDate>Sat, 04 Apr 2026 16:03:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.2</generator>
		<item>
		<title>Futurum website is: https://futurumgroup.info &#8211; not futurum.info as in the previous news attachment</title>
		<link>http://www.regentherapeutics.com/futurum-website-is-httpsfuturumgroup-info-not-futurum-info-as-in-the-previous-news-attachment/</link>
		<comments>http://www.regentherapeutics.com/futurum-website-is-httpsfuturumgroup-info-not-futurum-info-as-in-the-previous-news-attachment/#comments</comments>
		<pubDate>Sat, 04 Apr 2026 16:03:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1617</guid>
		<description><![CDATA[]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/futurum-website-is-httpsfuturumgroup-info-not-futurum-info-as-in-the-previous-news-attachment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Urgent Call to ReGen Shareholders not Aware of the Ongoing Merger/Rights Issue</title>
		<link>http://www.regentherapeutics.com/urgent-call-to-regen-shareholders-not-aware-of-the-ongoing-mergerrights-issue/</link>
		<comments>http://www.regentherapeutics.com/urgent-call-to-regen-shareholders-not-aware-of-the-ongoing-mergerrights-issue/#comments</comments>
		<pubDate>Sat, 04 Apr 2026 14:36:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1612</guid>
		<description><![CDATA[Merger Announcement Website 040426 Urgent call to Shareholders Rights Issue 040426]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/urgent-call-to-regen-shareholders-not-aware-of-the-ongoing-mergerrights-issue/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Report and Unaudited Financial Statements Year ended 31st December 2019</title>
		<link>http://www.regentherapeutics.com/report-and-unaudited-financial-statements-year-ended-31st-december-2019/</link>
		<comments>http://www.regentherapeutics.com/report-and-unaudited-financial-statements-year-ended-31st-december-2019/#comments</comments>
		<pubDate>Mon, 10 May 2021 15:00:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1593</guid>
		<description><![CDATA[Regen Therapeutics Ltd 2019 accs Final]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/report-and-unaudited-financial-statements-year-ended-31st-december-2019/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Shareholder Update: One Year On From Transferring Colostrinin Rights To Sterling</title>
		<link>http://www.regentherapeutics.com/shareholder-update-one-year-on-from-transferring-colostrinin-rights-to-sterling/</link>
		<comments>http://www.regentherapeutics.com/shareholder-update-one-year-on-from-transferring-colostrinin-rights-to-sterling/#comments</comments>
		<pubDate>Wed, 12 Jun 2019 16:55:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1583</guid>
		<description><![CDATA[Shareholder Update June 2019]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/shareholder-update-one-year-on-from-transferring-colostrinin-rights-to-sterling/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sale of ‘Colostrinin’ Assets to Sterling Technology Inc.</title>
		<link>http://www.regentherapeutics.com/sale-of-colostrinin-assets-to-sterling-technology-inc-13-0618/</link>
		<comments>http://www.regentherapeutics.com/sale-of-colostrinin-assets-to-sterling-technology-inc-13-0618/#comments</comments>
		<pubDate>Wed, 13 Jun 2018 08:02:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1574</guid>
		<description><![CDATA[Dear Shareholder, Apologies for not having contacted you for so long, but we have been working hard to find new distributors for Colostrinin and even an outright buyer for the company as a going concern. We have done this whilst continuing to minimize costs eg. letting expensive patents lapse and continuing to defer salaries. With [...]]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/sale-of-colostrinin-assets-to-sterling-technology-inc-13-0618/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unaudited Financial Statements Year 2015</title>
		<link>http://www.regentherapeutics.com/unaudited-financial-statements-year-2015/</link>
		<comments>http://www.regentherapeutics.com/unaudited-financial-statements-year-2015/#comments</comments>
		<pubDate>Fri, 04 Nov 2016 12:09:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1566</guid>
		<description><![CDATA[ReGen Therapeutics Ltd 2015 Unaudited Financial Statements ]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/unaudited-financial-statements-year-2015/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ReGen Therapeutics Ltd Year end Accounts 2014</title>
		<link>http://www.regentherapeutics.com/regen-therapeutics-ltd-year-end-accounts-2014/</link>
		<comments>http://www.regentherapeutics.com/regen-therapeutics-ltd-year-end-accounts-2014/#comments</comments>
		<pubDate>Thu, 01 Oct 2015 08:02:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1559</guid>
		<description><![CDATA[Regen Therapeutics Ltd Year end 2014 accounts]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/regen-therapeutics-ltd-year-end-accounts-2014/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ReGen Therapeutics Limited. Report and Accounts 2013</title>
		<link>http://www.regentherapeutics.com/regen-therapeutics-limited-report-and-accounts-2013/</link>
		<comments>http://www.regentherapeutics.com/regen-therapeutics-limited-report-and-accounts-2013/#comments</comments>
		<pubDate>Wed, 05 Nov 2014 10:56:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1554</guid>
		<description><![CDATA[Regen Therapeutics Ltd 2013 accs FINAL]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/regen-therapeutics-limited-report-and-accounts-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Shareholder Update 9th December 2013</title>
		<link>http://www.regentherapeutics.com/shareholder-update-9th-december-2013/</link>
		<comments>http://www.regentherapeutics.com/shareholder-update-9th-december-2013/#comments</comments>
		<pubDate>Mon, 09 Dec 2013 14:37:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1545</guid>
		<description><![CDATA[&#160; ReGen Therapeutics Limited – Shareholder Update 9th December 2013  Dear shareholder,  By way of a brief update to the statement made on 30/9/13 (as part of the Report and Financial Statements of the Company for the Year ended December 2012) : Sales revenues for Colostrinin have continued to be poor during 2013, largely as [...]]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/shareholder-update-9th-december-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Report and Financial Statements &#8211; Year Ended December 2012</title>
		<link>http://www.regentherapeutics.com/report-and-financial-statements-year-ended-december-2012/</link>
		<comments>http://www.regentherapeutics.com/report-and-financial-statements-year-ended-december-2012/#comments</comments>
		<pubDate>Mon, 30 Sep 2013 10:45:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.regentherapeutics.com/?p=1520</guid>
		<description><![CDATA[Revenues from sales of ColostrininTM for the year to 31 December 2012 were £65,000.  For comparison purposes previously reported sales were £104,000 for 2011, £187,741 for 2010 and £56,055 for 2009. While it appears that overheads have gone up from last year (2012 &#8211; £197,000 : 2011 &#8211; £170,000) it must be borne in mind [...]]]></description>
		<wfw:commentRss>http://www.regentherapeutics.com/report-and-financial-statements-year-ended-december-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
